A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.
|
16952549
|
Gastroenterology
|
A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
|
15107828
|
Oncogene
|
A new specific gene expression in squamous cell carcinoma of the esophagus detected using representational difference analysis and cDNA microarray.
|
16446548
|
Oncology
|
Aberrant methylation of Reprimo in human malignancies.
|
15700311
|
Int. J. Cancer
|
Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.
|
12067979
|
Cancer Res.
|
Aberrant promoter methylation of multiple genes during multistep pathogenesis of colorectal cancers.
|
16108009
|
Int. J. Cancer
|
Activation of the esophagin promoter during esophageal epithelial cell differentiation.
|
12036303
|
Genomics
|
Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
|
15520171
|
Cancer Res.
|
An ultrasensitive new DNA microarray chip provides gene expression profiles for preoperative esophageal cancer biopsies without RNA amplification.
|
18511875
|
Oncology
|
An unsupervised approach to identify molecular phenotypic components influencing breast cancer features.
|
14996713
|
Cancer Res.
|
Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer.
|
11964046
|
Virchows Arch.
|
Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon.
|
12101425
|
Oncogene
|
Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer.
|
12067993
|
Cancer Res.
|
Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions.
|
11874992
|
Gastroenterology
|
Beyond Field Effect: Analysis of Shrunken Centroids in Normal Esophageal Epithelia Detects Concomitant Esophageal Adenocarcinoma.
|
18425214
|
Bioinform Biol Insights
|
Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression.
|
15221970
|
Int. J. Cancer
|
Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.
|
23996928
|
Carcinogenesis
|
Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays.
|
11821959
|
Oncogene
|
HNPCC-associated small bowel cancer: clinical and molecular characteristics.
|
15765394
|
Gastroenterology
|
Hypermethylation of tachykinin-1 is a potential biomarker in human esophageal cancer.
|
17975140
|
Clin. Cancer Res.
|
Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
|
18199717
|
Cancer Epidemiol. Biomarkers Prev.
|
Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia.
|
11313962
|
Oncogene
|
Hypermethylation of the nel-like 1 gene is a common and early event and is associated with poor prognosis in early-stage esophageal adenocarcinoma.
|
17452981
|
Oncogene
|
Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.
|
11861396
|
Cancer Res.
|
Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning.
|
15059896
|
Cancer Res.
|
Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
|
15824739
|
Oncogene
|
Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers.
|
12097267
|
Cancer Res.
|
Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability.
|
11507051
|
Cancer Res.
|
Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors.
|
14691305
|
Lab. Invest.
|
Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability.
|
16012936
|
Gastroenterology
|
Mutational and LOH analyses of the chromosome 4q region in esophageal adenocarcinoma.
|
16837775
|
Oncology
|
Novel decapeptides that bind avidly and deliver radioisotope to colon cancer cells.
|
17912343
|
PLoS ONE
|
Polo-like kinase and survivin are esophageal tumor-specific promoters.
|
16487489
|
Biochem. Biophys. Res. Commun.
|
Prediction of lymph node metastasis with use of artificial neural networks based on gene expression profiles in esophageal squamous cell carcinoma.
|
15545505
|
Ann. Surg. Oncol.
|
Prediction of survival in patients with esophageal carcinoma using artificial neural networks.
|
15751017
|
Cancer
|
Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors.
|
18729198
|
Int. J. Cancer
|
Promoter methylation and response to chemotherapy and radiation in esophageal cancer.
|
16678495
|
Clin. Gastroenterol. Hepatol.
|
Promoter methylation regulates cyclooxygenase expression in breast cancer.
|
15217498
|
Breast Cancer Res.
|
RAB32 hypermethylation and microsatellite instability in gastric and endometrial adenocarcinomas.
|
16557577
|
Int. J. Cancer
|
Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
|
17408633
|
Gastroenterology
|
Rarity of Somatic Mutation and Frequency of Normal Sequence Variation Detected in Sporadic Colon Adenocarcinoma Using High-Throughput cDNA Sequencing.
|
18389087
|
Bioinform Biol Insights
|
Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.
|
17121882
|
Clin. Cancer Res.
|
Sparse logistic regression with Lp penalty for biomarker identification.
|
17402921
|
Stat Appl Genet Mol Biol
|
Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis.
|
15574757
|
Cancer Res.
|
Thapsigargin resistance in human prostate cancer cells.
|
16770788
|
Cancer
|
The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
|
16172218
|
Cancer Epidemiol. Biomarkers Prev.
|
Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features.
|
18382671
|
PLoS ONE
|
Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis.
|
16449976
|
Oncogene
|
Transcriptional responses of intestinal epithelial cells to infection with Vibrio cholerae.
|
15213169
|
Infect. Immun.
|